Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells

Cancer Letters

Volumn 174, Issue 2, 2001, Pages 127-134

  Um, Soo Jong ^a   Lee, So Young ^b   Kim, Eun Joo ^b   Han, Hye Sook ^a   Koh, Youmg Me ^b   Hong, Kyoung Ja ^b   Sin, Hong Sig ^c   Park, Jong Sup ^b  

^a Sejong University   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Chebigen   (South Korea)

Author keywords

4 HPR; Apotosis; Invasion; Ovarian cancers; Retinoid derivatives

Indexed keywords

ALITRETINOIN; FENRETINIDE; ISOTRETINOIN; RETINOIC ACID; RETINOID DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STAGING; CELL ACTIVITY; CELL INVASION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; GENETIC TRANSFECTION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; IC 50; OVARY CANCER; OVARY CELL; PRIORITY JOURNAL;

ANTICARCINOGENIC AGENTS; CELL DIVISION; DNA FRAGMENTATION; DNA, NEOPLASM; FEMALE; FENRETINIDE; HUMANS; OVARIAN NEOPLASMS; RECEPTORS, RETINOIC ACID; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

ATRA;

EID: 0035965941     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00697-8     Document Type: Article

References (41)

1. Current status of chemotherapy for ovarian cancer
2. Cellular biology and biochemistry of the retinoids
3. Retinoids as modulators of tumor cells invasion and metastasis
4. Retinoids-'differentiation agents' for cancer treatment and prevention
5. Retinoids and cancer: A basis for differentiation therapy
6. The retinoid receptors
7. Antagonism between retinoic acid receptors and AP-1: Implications for tumor promotion and inflammation
8. Therapeutic potential of selective modulators of nuclear receptor action
9. Molecular mechanisms of retinoid actions in skin
10. Retinoids and ovarian cancer
11. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: Cooperative growth suppression of IRF-1 and p53
12. Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells
13. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells
14. Vitamin A
15. Bioactivities of N-(4-hydroxyphenyl)retinamide and retinoyl β-glucuronide
16. 4-Hydroxyphenylretinamide in the chemoprevention of cancer
17. Suppressions of rat mammary cancer development by 4-HPR following surgical removal of first palpable tumor
18. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide
19. Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide
20. Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity
21. Can fenretinide protect women against ovarian cancer?
22. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines
23. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression
24. Effect of N-(4-hydroxyphenyl)retinamide on apoptosis in human breast cancer cells
25. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide induced apoptosis in cervical carcinoma cells
26. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines
27. N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell death
28. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines
29. Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR)
30. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors
31. Nuclear receptor/AP-1 interaction
32. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP-1 binding site
33. Retinoic acid is a negative regulator of AP-1-responsive genes
34. The role of jun, fos and the AP-1 complex in cell proliferation and transformation
35. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation
36. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha
37. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation
38. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element
39. Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1-mediated transrepression
40. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid
41. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells